Prelude Fertility

Founded in 2015 by Martin Varsavsky and funded by Lee Equity Partners in 2016, Prelude Fertility is a reproductive health and technology company dedicated to providing comprehensive fertility care. Its core mission is to educate individuals about their reproductive health and offer the best options, science, and care to help them become parents when they are ready. Prelude Fertility operates a network of fertility clinics across the United States, offering services such as in vitro fertilization (IVF), intrauterine insemination (IUI), fertility preservation, and genetic testing.

Notable affiliated individuals include founder Martin Varsavsky, an entrepreneur known for his innovative ventures. The company has achieved significant milestones, including establishing a robust network of clinics and becoming a trusted name in fertility care. With its advanced technology and patient-centric approach, Prelude Fertility has made a substantial impact on the reproductive health industry, helping countless individuals and couples achieve their dreams of parenthood.